Folic acid antagonists during pregnancy and risk of birth defects.
Brentlinger
P E
PE
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000890:Anti-Infective Agents / Q000009:adverse effects; D002971:Cleft Lip / Q000139:chemically induced; D005260:Female; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D015658:HIV Infections / Q000188:drug therapy*; D006330:Heart Defects, Congenital / Q000139:chemically induced; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*; D014551:Urinary Tract / Q000002:abnormalities
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D015662:Trimethoprim, Sulfamethoxazole Drug Combination